Business Context and Reporting Period
Company: GoodRx Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date: November 10, 2022
Event: The Company entered into a definitive asset purchase agreement to sell its backend virtual care technology to Wheel Health, Inc. ("Wheel").
Key Financial Metrics
Transaction Value: $19.5 million in cash.
Expected Closing: End of November 2022, subject to customary conditions.
Other Metrics: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period.
Material Changes
- Asset Sale: GoodRx is divesting its backend virtual care technology assets to Wheel Health.
- Operational Continuity: Post-closing, GoodRx will enter into a licensing agreement with Wheel to continue using the sold technology and staffing services to provide telehealth services via the GoodRx Care platform.
Guidance, Outlook, and Risks
Management Commentary: The transaction is expected to close by the end of November 2022. The Company anticipates continuing to offer telehealth services to consumers through the GoodRx Care platform using Wheel's technology following the sale.
Risks and Contingencies:
- The proposed sale may not be completed in a timely manner or at all.
- The Company may not recognize the expected benefits from the sale.
- The transaction may involve unexpected costs, liabilities, or delays.
- Forward-looking statements are subject to risks detailed in the Company's Form 10-K and Form 10-Q filings.
Investor Verification Checklist
- Confirm the final closing date of the asset purchase agreement with Wheel Health.
- Verify the specific terms of the ancillary licensing agreement regarding technology access and staffing services.
- Monitor for any unexpected costs or liabilities associated with the divestiture.
- Review the impact of this transaction on future telehealth service delivery and cost structures.